LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) will release its financial results for the fourth quarter 2021 (4Q21) on Wednesday, February 2, 2022 at 6:30 a.m. Eastern time. The company wi

UnitedHealth (UNH) Unit Invests to Improve Members' Eye Health

03:02pm, Wednesday, 12'th Jan 2022 Zacks Investment Research
UnitedHealth Group's (UNH) business, UnitedHealthcare, offers discount programs and invests in school districts in an effort to improve the eye health of its vision members.
Shares of Humana Inc. HUM, +1.68% rallied 1.4% in premarket trading Wednesday, after the health insurer disclosed a $1.0 billion accelerated share repurchase agreement. The ASR, which is part of the $
Humana on Track for Largest Percent Increase in Over a Year Data Talk Morningstar.com
The stock of Humana has seen a large fall of 17% over the last month, while it was down around 22% last week. HUM stock rose from levels of around $390 in early October 2021 to levels of around $470 t
Here are 3 ugly charts of great stocks to buy on dips. Investor sentiment is largely to blame, so there will be buyers lurking below.

The 1-Minute Market Report - January 8, 2022

06:35am, Monday, 10'th Jan 2022 Seeking Alpha
Commodities were the only major index to gain ground last week. Read here for a detailed review...
The worst performers in 2022's first week of trading include Humana, Moderna, Netflix and Salesforce.com.
Shares of Clover Health are declining today due to Humana lowering its membership forecast and Credit Suisse issuing a downgrade.
Shares of Humana Inc. continued their plunge toward a near two-year low Friday, as some Wall Street analysts expressed concern that there isn't a fast fix to the health insurance services company's Me

Humana (HUM) Cuts Medicare Enrollment Outlook, Tumbles 19.4%

02:42pm, Friday, 07'th Jan 2022 Zacks Investment Research
Humana (HUM) expects Group Medicare Advantage membership to remain flat in 2022, with competitive pricing possibly playing a crucial role.
Shares of Humana Inc. extended their plunge toward a near two-year low on Friday, as some Wall Street analysts expressed concern that there isn't a fast fix to the health insurance services company's
Humana (HUM) expects Group Medicare Advantage membership to remain flat in 2022, with competitive pricing possibly playing a crucial role.
Shares of UnitedHealth Group Inc. dropped 3.7% in afternoon trading Thursday, enough to pace the Dow Jones Industrial Average''s components in declines. The $18.22 price decline in the health insurance company''s stock was shaving about 120 points off the price of the Dow, which was dropping 144 points, or 0.4%. In comparison, the S&P 500 was up 0.1%. The selloff in UnitedHealth''s stock comes after peer Humana Inc. slashed its estimate of 2022 Medicare Advantage membership growth, amid higher-than-expected terminations during the annual election period. Humana''s stock plunged 19.7%. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE